Health ASCO 2023: IDH mutation and improved cognitive functions in brain tumor patients by Alexandra Hartman Editor-in-Chief June 4, 2023 written by Alexandra Hartman Editor-in-Chief June 4, 2023 47 2023-06-04 12:19:42 – ASCO 2023 ASCO 2023 Patients with this tumor with the IDH 1 and 2 mutation improve their motor and cognitive functions, in addition to avoiding long-term relapses. Grade 2 gliomas with a mutation in the IDH gene are malignant brain tumors that cause considerable morbidity and premature death. 1685882522 #Vorasidenib #stops #grade #glioma #surgery #delays #chemo #radium Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X 0 comments 0 FacebookTwitterPinterestEmail Alexandra Hartman Editor-in-Chief Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity. previous post Despite Dementia, Bruce Willis Enjoys a Day at Disneyland with Wife and Children next post Amazon is negotiating with US carriers to provide low-cost mobile phone service You may also like Cancer’s Immune Evasion Blocked by Blocking LCN2 Protein,... February 18, 2026 Asperger’s Syndrome: Signs, Symptoms & Awareness Day (Feb... February 18, 2026 Cremation Process & Doctors on Talking About Death February 18, 2026 Survival Epidemiology: New Field Improves Post-Diagnosis Outcomes February 18, 2026 Outbreak Investigation & Pathogen Detection in DRC: Methods... February 18, 2026 Patrice Aminati: Positive News Despite Cancer Diagnosis February 18, 2026 UK Covid Inquiry: Module 10 Focuses on Vulnerable... February 18, 2026 Heart Disease & Stroke in Canada: Stats &... February 18, 2026 Strawberries for Athletes: 5 Benefits & Why to... February 18, 2026 11 New Costco Finds Everyone’s Buying This February February 18, 2026 Leave a Comment Cancel Reply Δ This site uses Akismet to reduce spam. Learn how your comment data is processed.
